Overview
Fyza Shaikh is an Assistant Professor in Cancer Immunology in the Department of Oncology in the Sidney Kimmel Comprehensive Cancer Center. She joined the faculty after completing her fellowship in medical oncology at Johns Hopkins School of Medicine (JHSOM) and residency in internal medicine at the University of Pittsburgh Medical Center as part of the ABIM research pathway. She received her MD and PhD in Microbiology and Immunology at Vanderbilt University School of Medicine. The Shaikh lab at JHSOM is focused on how the microbiome impacts host immunological responses to tumorigenesis and anti-tumor responses to immunomodulatory agents. The lab uses a combination of translational approaches using samples collected from human cohort studies and clinical trials as well as murine models to ask more detailed mechanistic questions and works across multiple tumor types (melanoma, lung, esophageal, head and neck, etc). The overall approach uses combination of clinical, computational, and lab-based techniques using a rich biorepository containing clinically annotated metadata with known and putative biomarkers of ICI response, such as PD-L1 and tumor mutational burden, paired with longitudinal fecal and plasma samples that correlate with clinical milestones (i.e. response/nonresponse by imaging and treatment-related toxicity). The goal is to focus on microbial functionality and build defined bacterial consortia that can then be tested in murine models to define colonization, metabolomics, and intra-tumoral immune response. This translational approach, with cross-sectional and longitudinal analysis of human samples, paired with mechanistic studies in murine models, has the potential to address both limitations in previously published studies and generate new hypotheses to make advances in this field and improve ICI responses for patients with advanced malignancies.
Dr. Shaikh is rated as an Experienced provider by MediFind in the treatment of Stomach Cancer. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Melanoma, and Esophageal Cancer.
Her clinical research consists of co-authoring 17 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Stomach Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
Locations
Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Skip Viragh Outpatient Cancer Center
Dr. Katherine Bever is a medical oncologist in Baltimore, caring for patients with gastrointestinal malignancies, including gastric, pancreatic, colorectal, neuroendocrine and biliary cancers. Dr. Bever received her undergraduate degree in biophysics from Johns Hopkins University. She earned her M.D. from the University of Maryland School of Medicine. She completed her residency in internal medicine at Boston University School of Medicine and performed a fellowship in medical oncology at Johns Hopkins. Dr. Bever joined the Johns Hopkins faculty in 2015. Prior to joining Johns Hopkins, Dr. Bever was an internist at the Amyloidosis Center at Boston University School of Medicine. Dr. Bever was recognized with a Pearl M. Stetler Fellowship Award in 2018. She is a member of several professional organizations, including the Society for Immunotherapy of Cancer, the American Association of Clinical Research and the American Society of Clinical Oncology. Dr. Bever is rated as an Advanced provider by MediFind in the treatment of Stomach Cancer. Her top areas of expertise are Stomach Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, Appendix Cancer, and Pancreaticoduodenectomy.
Inova Health Care Services
Timothy Cannon is an Oncologist and a Hematologist in Falls Church, Virginia. Dr. Cannon is rated as a Distinguished provider by MediFind in the treatment of Stomach Cancer. His top areas of expertise are Colorectal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Cholangiocarcinoma (Bile Duct Cancer). Dr. Cannon is currently accepting new patients.
University Of Maryland Oncology Associates PA
Yixing Jiang is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Jiang is rated as a Distinguished provider by MediFind in the treatment of Stomach Cancer. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Familial Pancreatic Cancer, Anal Cancer, and Gastrostomy. Dr. Jiang is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Esophageal CancerDr. Shaikh isExperienced. Learn about Esophageal Cancer.
- Gallbladder AdenocarcinomaDr. Shaikh isExperienced. Learn about Gallbladder Adenocarcinoma.
- Gallbladder CancerDr. Shaikh isExperienced. Learn about Gallbladder Cancer.
- Lung CancerDr. Shaikh isExperienced. Learn about Lung Cancer.
- MelanomaDr. Shaikh isExperienced. Learn about Melanoma.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Shaikh isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).